These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 666451)

  • 1. Suppression of voluntary ingestion of morphine by inhibition of dopamine-beta-hydroxylase.
    Brown ZW; Amit Z; Sinyor D; Rockman GE; Ogren SO
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):102-10. PubMed ID: 666451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta-hydroxylase inhibition.
    Amit Z; Brown ZW; Levitan DE; Ogren SO
    Arch Int Pharmacodyn Ther; 1977 Nov; 230(1):65-75. PubMed ID: 603310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenergic mediation of the positive reinforcing properties of ethanol: II. Extinction of ethanol-drinking behavior in laboratory rats by inhibition of dopamine-beta-hydroxylase. Implications for treatment procedures in human alcoholics.
    Brown ZW; Amit Z; Levitan DE; Ogren SO; Sutherland EA
    Arch Int Pharmacodyn Ther; 1977 Nov; 230(1):76-82. PubMed ID: 603311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of voluntary morphine consumption following treatment with zimelidine.
    Rockman GE; Amit Z; Bourque C; Brown ZW; Ogren SO
    Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):123-9. PubMed ID: 6448029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats.
    Amit Z; Levitan DE; Lindros KO
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):114-9. PubMed ID: 999391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for inhibition of dopamine-beta-hydroxylase in vivo after sub-acute pyrazole treatment in rats.
    MacDonald E; Pispa JP
    Med Biol; 1977 Oct; 55(5):284-91. PubMed ID: 22792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1-phenyl-3-(2-thiazolyl)-2-thiourea, a dopamine beta-hydroxylase inhibitor on morphine analgesia, tolerance and physical dependence.
    Bhargava HN; Way EL
    J Pharmacol Exp Ther; 1974 Jul; 190(1):165-75. PubMed ID: 4858783
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of dopamine-beta-hydroxylase inhibition on the cardiovascular and respiratory actions of dopamine in rats.
    Riancho JA; del Arco C; Pazos A; Flórez J
    Rev Esp Fisiol; 1982 Dec; 38(4):461-9. PubMed ID: 7170431
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine beta-hydroxylase inhibition reveals a selective influence of endotoxin on catecholamine content of rat tissues.
    Arnold J; Choo JJ; Little RA; Rothwell NJ
    Circ Shock; 1990 Aug; 31(4):387-94. PubMed ID: 2204497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of castration on the smooth muscle cells of the internal sex organs of the rat: influence of the smooth muscle on the sympathetic neurons innervating the vas deferens, seminal vesicle and coagulating gland.
    Wakade AR; Garcia AG; Kirpekar SM
    J Pharmacol Exp Ther; 1975 May; 193(2):424-34. PubMed ID: 1142099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased dopamine concentration in the striatum in the mouse by FLA-63, a dopamine- -hydroxylase inhibitor.
    Svensson TH
    J Pharm Pharmacol; 1973 Jan; 25(1):73-5. PubMed ID: 4146204
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor. III. Effects on endogenous biogenic amine levels in rats.
    Ishii Y; Homma M; Yoshikawa A; Umezawa H
    Arzneimittelforschung; 1975 Mar; 25(3):383-5. PubMed ID: 1174036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-beta-hydroxylase inhibitors, feeding and locomotor activity: reinstatement of feeding following central norepinephrine.
    Evans KR; Beninger RJ; Eikelboom R
    Pharmacol Biochem Behav; 1985 Apr; 22(4):535-40. PubMed ID: 3991764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of voluntary ethanol consumption by dopamine-beta-hydroxylase inhibition (FLA-57): mediated by changes in aversion, reinforcement or both.
    Amit Z; Gill K; Ng Cheong Ton JM
    Alcohol; 1991; 8(2):79-85. PubMed ID: 2064756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological analysis of certain mechanisms of morphine addiction.
    Ovcharov R; Bantoutova I; Kobourova K
    Acta Physiol Pharmacol Bulg; 1976; 2(2):68-74. PubMed ID: 1035029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and their regulation by chronic morphine in the mesolimbic dopamine system.
    Guitart X; Beitner-Johnson D; Marby DW; Kosten TA; Nestler EJ
    Synapse; 1992 Nov; 12(3):242-53. PubMed ID: 1362292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha-adrenergic blocking agents on narcotic-induced analgesia.
    Cicero TJ
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):5-13. PubMed ID: 4152529
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions of pyrazole and ethanol on norepinephrine metabolism in rat brain.
    Brown FC; Zawad J; Harralson JD
    J Pharmacol Exp Ther; 1978 Jul; 206(1):75-80. PubMed ID: 660560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.